logobeta
본 영문본은 리걸엔진의 AI 번역 엔진으로 번역되었습니다. 수정이 필요한 부분이 있는 경우 피드백 부탁드립니다.
텍스트 조절
arrow
arrow
(영문) 서울서부지방법원 2019.07.12 2018고정949
의료법위반
Text

The sentence of sentence against the defendant shall be suspended.

Reasons

Punishment of the crime

Defendant (former name: B) is a person who had been working as D and major at C Hospital from March 201 to February 2015 after obtaining a medical license on February 2010.

A medical person shall not receive money, goods, benefits, labor, entertainment, or other economic benefits provided by a drug supplier, such as a drug wholesaler, etc. for the purpose of sales promotion, such as adoption of drugs, inducement of prescription, maintenance of transaction, etc.

Nevertheless, on January 2014, the Defendant received a proposal from (i) FF business G, a pharmaceutical company, to pay a total of KRW 550,000 in cash in the same manner eight times from May 2014, and received KRW 2,90,000 in cash from (ii) the Defendant received a proposal from (ii) FF business G, which is a pharmaceutical product manufactured and sold by (iii)F, and (iv) received KRW 550,000 in cash.

Accordingly, the Defendant, as a medical person, received KRW 2.9 million for the purpose of promoting the sale of medicines from a medicine supplier.

Summary of Evidence

1. Defendant's legal statement;

1. Legal statement of witness G;

1. Application of a copy of business pocket book;

1. Relevant legal provisions concerning criminal facts, the former Medical Service Act (amended by Act No. 14438, Dec. 20, 2016; hereinafter the same shall apply), the former Medical Service Act (amended by Act No. 14438, Dec. 20, 201; hereinafter the same shall apply), the former Medical Service Act’s proviso

1. Penalty surcharge of 2,00,000 won to be suspended and penalty of 2,900,000 won to be collected additionally; and

1. Articles 70(1) and 69(2) of the Criminal Act (100,000 won a day);

1. The latter part of Article 88-2 of the previous Medical Service Act;

1. Article 59(1) of the Criminal Act (i.e., violation of duty suspension; (ii) Article 59(1) of the same Act (see, e.g., Supreme Court Decisions 201Do141, Apr. 1, 2011; 201Do112

arrow